Literature DB >> 23201292

A sensitive real-time PCR based assay to estimate the impact of amino acid substitutions on the competitive replication fitness of human immunodeficiency virus type 1 in cell culture.

Yi Liu1, Sarah Holte, Ushnal Rao, Jan McClure, Philip Konopa, J Victor Swain, Erinn Lanxon-Cookson, Moon Kim, Lennie Chen, James I Mullins.   

Abstract

Fixation of mutations in human immunodeficiency virus type 1 (HIV-1), such as those conferring drug resistance and immune escape, can result in a change in replication fitness. To assess these changes, a real-time TaqMan PCR detection assay and statistical methods for data analysis were developed to estimate sensitively relative viral fitness in competitive viral replication experiments in cell culture. Chimeric viruses with the gene of interest in an HIV-1NL4-3 backbone were constructed in two forms, vifA (native vif gene in NL4-3) and vifB (vif gene with six synonymous nucleotide differences from vifA). Subsequently, mutations of interest were introduced into the chimeric viruses in NL4-3VifA backbones, and the mutants were competed against the chimera with the isogenic viral sequence in the NL4-3VifB backbone in cell culture. In order to assess subtle fitness differences, culture supernatants were sampled longitudinally, and the viruses differentially quantified using vifA- and vifB-specific primers in real-time PCR assays. Based on an exponential net growth model, the growth rate of each virus was determined and the fitness cost of the mutation(s) distinguishing the two viruses represented as the net growth rate difference between the mutant and the native variants. Using this assay, the fitness impact of eight amino acid substitutions was quantitated at highly conserved sites in HIV-1 Gag and Env. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23201292      PMCID: PMC3608845          DOI: 10.1016/j.jviromet.2012.10.016

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  33 in total

1.  Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost.

Authors:  Caroline S Fernandez; Ivan Stratov; Robert De Rose; Katrina Walsh; C Jane Dale; Miranda Z Smith; Michael B Agy; Shiu-Lok Hu; Kendall Krebs; David I Watkins; David H O'connor; Miles P Davenport; Stephen J Kent
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

2.  A novel real-time PCR assay to determine relative replication capacity for HIV-1 protease variants and/or reverse transcriptase variants.

Authors:  N M van Maarseveen; M C D G Huigen; D de Jong; A M Smits; C A B Boucher; M Nijhuis
Journal:  J Virol Methods       Date:  2005-12-20       Impact factor: 2.014

3.  Relative replication fitness of efavirenz-resistant mutants of HIV-1: correlation with frequency during clinical therapy and evidence of compensation for the reduced fitness of K103N + L100I by the nucleoside resistance mutation L74V.

Authors:  Christine E Koval; Carrie Dykes; Jiong Wang; Lisa M Demeter
Journal:  Virology       Date:  2006-06-21       Impact factor: 3.616

4.  Granulocyte-monocyte colony-stimulating factor upregulates HIV-1 replication in monocyte-derived macrophages cultured at low density.

Authors:  Janela McClure; Angélique B van't Wout; Trung Tran; John E Mittler
Journal:  J Acquir Immune Defic Syndr       Date:  2007-03-01       Impact factor: 3.731

5.  HIV protease resistance and viral fitness.

Authors:  Monique Nijhuis; Noortje M van Maarseveen; Charles A B Boucher
Journal:  Curr Opin HIV AIDS       Date:  2007-03       Impact factor: 4.283

6.  Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1.

Authors:  J Martinez-Picado; A V Savara; L Sutton; R T D'Aquila
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

7.  Quantitative 3D video microscopy of HIV transfer across T cell virological synapses.

Authors:  Wolfgang Hübner; Gregory P McNerney; Ping Chen; Benjamin M Dale; Ronald E Gordon; Frank Y S Chuang; Xiao-Dong Li; David M Asmuth; Thomas Huser; Benjamin K Chen
Journal:  Science       Date:  2009-03-27       Impact factor: 47.728

8.  Comparison of oligonucleotide ligation assay and consensus sequencing for detection of drug-resistant mutants of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and plasma.

Authors:  Giovanina M Ellis; Madhumita Mahalanabis; Ingrid A Beck; Gregory Pepper; Amy Wright; Shannon Hamilton; Sarah Holte; Willscott E Naugler; Diane M Pawluk; Chung-Chen Li; Lisa M Frenkel
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

9.  Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response.

Authors:  Ryan M Troyer; John McNevin; Yi Liu; Shao Chong Zhang; Randall W Krizan; Awet Abraha; Denis M Tebit; Hong Zhao; Santiago Avila; Michael A Lobritz; M Juliana McElrath; Sylvie Le Gall; James I Mullins; Eric J Arts
Journal:  PLoS Pathog       Date:  2009-04-03       Impact factor: 6.823

Review 10.  HIV-1 group M conserved elements vaccine.

Authors:  Morgane Rolland; David C Nickle; James I Mullins
Journal:  PLoS Pathog       Date:  2007-11       Impact factor: 6.823

View more
  12 in total

1.  Dendritic cells restore CD8+ T cell reactivity to autologous HIV-1.

Authors:  Kellie N Smith; Robbie B Mailliard; Brendan B Larsen; Kim Wong; Phalguni Gupta; James I Mullins; Charles R Rinaldo
Journal:  J Virol       Date:  2014-06-18       Impact factor: 5.103

2.  Epistasis and entrenchment of drug resistance in HIV-1 subtype B.

Authors:  Avik Biswas; Allan Haldane; Eddy Arnold; Ronald M Levy
Journal:  Elife       Date:  2019-10-08       Impact factor: 8.140

3.  Pairwise growth competition assay for determining the replication fitness of human immunodeficiency viruses.

Authors:  Siriphan Manocheewa; Erinn C Lanxon-Cookson; Yi Liu; J Victor Swain; Jan McClure; Ushnal Rao; Brandon Maust; Wenjie Deng; Justine E Sunshine; Moon Kim; Morgane Rolland; James I Mullins
Journal:  J Vis Exp       Date:  2015-05-04       Impact factor: 1.355

4.  Impact of mutations in highly conserved amino acids of the HIV-1 Gag-p24 and Env-gp120 proteins on viral replication in different genetic backgrounds.

Authors:  Yi Liu; Ushnal Rao; Jan McClure; Philip Konopa; Siriphan Manocheewa; Moon Kim; Lennie Chen; Ryan M Troyer; Denis M Tebit; Sarah Holte; Eric J Arts; James I Mullins
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

5.  Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells.

Authors:  Kellie N Smith; Robbie B Mailliard; Paolo A Piazza; Will Fischer; Bette T Korber; Ronald J Fecek; Deena Ratner; Phalguni Gupta; James I Mullins; Charles R Rinaldo
Journal:  mBio       Date:  2016-05-31       Impact factor: 7.867

6.  Fitness landscape of the human immunodeficiency virus envelope protein that is targeted by antibodies.

Authors:  Raymond H Y Louie; Kevin J Kaczorowski; John P Barton; Arup K Chakraborty; Matthew R McKay
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-08       Impact factor: 11.205

7.  Patterns and rates of viral evolution in HIV-1 subtype B infected females and males.

Authors:  Michael J Dapp; Kord M Kober; Lennie Chen; Dylan H Westfall; Kim Wong; Hong Zhao; Breana M Hall; Wenjie Deng; Thomas Sibley; Suvankar Ghorai; Katie Kim; Natalie Chen; Sarah McHugh; Lily Au; Mardge Cohen; Kathryn Anastos; James I Mullins
Journal:  PLoS One       Date:  2017-10-18       Impact factor: 3.240

8.  The HIV-1 Reverse Transcriptase A62V Mutation Influences Replication Fidelity and Viral Fitness in the Context of Multi-Drug-Resistant Mutations.

Authors:  José O Maldonado; Louis M Mansky
Journal:  Viruses       Date:  2018-07-19       Impact factor: 5.048

9.  GEMME: a simple and fast global epistatic model predicting mutational effects.

Authors:  Elodie Laine; Yasaman Karami; Alessandra Carbone
Journal:  Mol Biol Evol       Date:  2019-08-12       Impact factor: 16.240

10.  Fitness costs of mutations at the HIV-1 capsid hexamerization interface.

Authors:  Siriphan Manocheewa; J Victor Swain; Erinn Lanxon-Cookson; Morgane Rolland; James I Mullins
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.